Immunotoxin Therapy and Cytarabine in Treating Patients With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia
Clinical trial NCT01408160 · TERMINATED
Trial details
- NCT number
- NCT01408160
- Sponsor
- Albert Einstein College of Medicine
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-04-01
- Primary completion
- 2018-06-26
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.